ADC analysis on Gyrolab overcomes matrix effects, saving time, samples, and costs

This case study demonstrates how Gyrolab^® automated immunoassay technology enables reliable and efficient analysis of antibody-drug conjugates (ADCs) in complex biological matrices. Discover how by using a flow-through assay format, the platform reduces matrix effects and supports accurate quantification of ADC components, including total antibody, intact ADC, and degraded products. Case studies show that Gyrolab enables faster assay development, reduces sample and reagent consumption, and improves data quality compared to traditional ELISA and ECL methods.